Showing results (101-110 of 181) with videos related to
Sort By:
Pageof 19
European Journal of Medicinal Chemistry|February 10, 2026
Discovery and optimization of Menin-MLL inhibitors targeting acute myeloid leukemiaQitao Xiao, Yuxian Wang, Zheyuan Shen, et al.ACS Medicinal Chemistry Letters|February 18, 2026
Discovery of Novel ERK5 Inhibitors for Pancreatic Cancer via a Virtual Screening ApproachJingyu Zhang, Xinle Yang, Bingqian Huang, et al.Bioorganic Chemistry|July 29, 2025
Discovery of a ubiquitin-specific protease 10 inhibitor with high binding affinity promoting cell apoptosis via down-regulated CDK4 for the treatment of hepatocellular carcinomaYang Lu, Wentao Wang, Cheng Yuan, et al.Scientific Reports|February 26, 2025
Pentraxin3 exacerbates acute pancreatitis injury by inhibiting oxidative phosphorylation pathwayWenyue Wang, Yaning Wang, Chenchen Yuan, et al.European Journal of Medicinal Chemistry|October 31, 2023
Targeted delivery of cathepsin-activatable near-infrared fluorescence probe for ultrahigh specific imaging of peritoneal metastasisJialiang Lu, Yu Guo, Huimin Hao, et al.Journal of Medicinal Chemistry|September 26, 2023
Discovery of Novel Oxazepine Derivatives as Akt/ROCK Inhibitors for Growth Arrest and Differentiation Induction in Neuroblastoma TreatmentJinxin Che, Shaowei Bing, Jialiang Lu, et al.European Journal of Medicinal Chemistry|December 5, 2021
Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitorTian Niu, Kailin Li, Li Jiang, et al.European Journal of Medicinal Chemistry|November 13, 2021
Discovery of seneciobipyrrolidine derivatives for the amelioration of glucose homeostasis disorders through 4E-BP1/Akt/AMPK signaling activationJinxin Che, Canliang Ma, Jialiang Lu, et al.BMC Cancer|January 4, 2022
High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin LymphomaXi Chen, Haiying Kong, Linxiang Luo, et al.Bioorganic Chemistry|September 6, 2025
Discovery and characterization of sulfonamide derivatives as transcriptional enhanced associate domain (TEAD) inhibitors: a novel approach for targeting hepatocellular carcinomaYang Lu, Jian Gao, Jun Mo, et al.Pageof 19